Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs.
Our focus is the metabolic space (e.g. obesity, diabetes, MASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics.
Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise.
We work with some of the most interesting and loyal partners and customers from across the world in the pharmaceutical and biotech industry as well as academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.
Company Details
- Employees
- 279
- Founded
- -
- Address
- Hørsholm Kongevej 11b, Hoersholm,2970,denmark
- Phone
- +45 3152 2650
- in****@****ubra.dk
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gubra.dk
- Keywords
- in vivo pharmacology, histology, stereology, diabetes, obesity, NASH, Gastrointestinal diseases, peptide chemistry, molecular pharmacology, next generation sequencing, bioinformatics, ex vivo assays, Imaging.
- HQ
- Hoersholm
Gubra Questions
Gubra's helpline number is +45 3152 2650
Gubra's website is gubra.dk
Gubra's LinkedIn profile is https://dk.linkedin.com/company/gubra
Gubra has
279 employees.
View email and phone details for 279
employees at Gubra.
Gubra's industry is
Biotechnology Research
Gubra's top competitors are
Zealand Pharma,
Nordic Bioscience,
Bavarian Nordic,
Bioinnovation Institute,
Evaxion A/s,
Novonesis,
Lundbeck,
Minerva Imaging,
Genmab,
Novo Nordisk.
Gubra's support email address is info@gubra.dk
Gubra's categories are Biotechnology Research
Gubra's founding year is 2008
